Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2019-07-01
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The survey contains specific questions and dedicated case presentations on two major topics.
The first part queries the characteristics of the participants, including overall experience in interventional cardiology, annual volume of percutaneous coronary intervention (PCI), and duration of experience with quantitative coronary angiography (QCA), intravascular ultrasound (IVUS),optical coherence tomography (OCT), fractional flow reserve (FFR) and non-hyperaemic pressure ratios (NHPR). The survey uses here predefined categories and single-choice questions.
The second part investigates personal strategies for evaluating angiographically intermediate stenoses in the catheterization laboratory. Here, participants are asked to evaluate 5 complete coronary angiograms. All cases are characterised as stable angina without relevant changes on resting ECG. No information about non-invasive testing is known or provided.
Here participants are asked to (1) localise all relevant stenoses by indicating the involved segment; (2) define percent diameter stenosis (%DS) by visual estimate; and (3) determine the significance of the stenosis of interest. In cases of angiographic uncertainty, the preferred diagnostic tool is asked to be selected from the arsenal available in the catheterisation laboratory, namely QCA, IVUS, OCT, FFR or NHPR. Participants are asked to make their decisions assuming ideal world conditions, without considering any financial restrictions or local regulations, but only after the best clinical practice achievable in this virtual catheterisation laboratory.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Level of experience in interventional cardiology
Total cohort will be grouped according to experience in interventional cardiology, as defined by a single choice questionnaire:
Yearly personal PCI volume Less than 75 / Between 75 and 150 / Between 151 and 250 / More than 250
No interventions assigned to this group
Level of experience with intravascular ultrasound
Total cohort will be grouped according to experience with intravascular ultrasound, as defined by a single choice questionnaire:
General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years
Yearly: None / Less than 15 / Between 15 and 50 / More than 50
No interventions assigned to this group
Level of experience with optical coherence tomography
Total cohort will be grouped according to experience with optical coherence tomography, as defined by a single choice questionnaire:
General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years
Yearly: None / Less than 15 / Between 15 and 50 / More than 50
No interventions assigned to this group
Level of experience with fractional flow reserve
Total cohort will be grouped according to experience with fractional flow reserve, as defined by a single choice questionnaire:
General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years
Yearly: None / Less than 50 / Between 50 and 150 / Between 151 and 250 / More than 250
No interventions assigned to this group
Level of experience with non-hyperaemic pressure ratios
Total cohort will be grouped according to experience with non-hyperaemic pressure ratios, as defined by a single choice questionnaire:
General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years
Yearly: None / Less than 50 / Between 50 and 150 / Between 151 and 250 / More than 250
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Interventional cardiologists in training
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gabor Toth-Gayor
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Toth GG, Toth B, Johnson NP, De Vroey F, Di Serafino L, Pyxaras S, Rusinaru D, Di Gioia G, Pellicano M, Barbato E, Van Mieghem C, Heyndrickx GR, De Bruyne B, Wijns W. Revascularization decisions in patients with stable angina and intermediate lesions: results of the international survey on interventional strategy. Circ Cardiovasc Interv. 2014 Dec;7(6):751-9. doi: 10.1161/CIRCINTERVENTIONS.114.001608. Epub 2014 Oct 21.
G Toth G, Johnson NP, Wijns W, Toth B, Achim A, Fournier S, Barbato E. Revascularization decisions in patients with chronic coronary syndromes: Results of the second International Survey on Interventional Strategy (ISIS-2). Int J Cardiol. 2021 Aug 1;336:38-44. doi: 10.1016/j.ijcard.2021.05.005. Epub 2021 May 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISIS 2
Identifier Type: -
Identifier Source: org_study_id